Pharma Marketing’s New Frontier: Leveraging Content Subtype for Superior and Faster Reviews

March 6, 2024
Annalise Ludtke

 

Exploring the pivotal aspects of promotional content review in the pharmaceutical industry, the 2023 State of Promotional Review Benchmark Report presented in the Benchmarks Symposium series sheds light on the intricacies of job duration metrics by content subtype. Hosted by Annalise Ludtke, the Senior Manager of Marketing and Communications at Vodori , with the expertise of Dr. Joe DiCapite, the Director of Strategy at UK and Europe Vodori , this episode navigates through the diverse challenges and considerations involved in reviewing and approving various types of promotional content. Dr. DiCapite’s rich background in pharmaceuticals provides a detailed perspective on the importance of understanding these metrics for efficient planning and benchmarking against industry standards.

The discussion emphasizes how different content types, from social media to videos and podcasts, impact review durations and highlights the significance of such data for strategic planning and process improvement. By delving into factors that affect job duration, such as content complexity, size, and risk, the episode offers valuable insights into optimizing review processes. This analysis not only aids pharmaceutical companies in enhancing their promotional strategies but also ensures that critical medications are efficiently delivered to the right patients. The emphasis on content subtype highlights the strategic value of benchmark data in the promotional review process, providing a roadmap for enhancing efficiency and effectiveness in pharmaceutical marketing.

Recent Episodes

MSK populations
View episode

Discover how a dynamic duo partnered with innovative, value-based strategies to revolutionize care for MSK populations. As musculoskeletal (MSK) conditions like osteoarthritis and back pain continue to rise, innovative partnerships are vital to delivering effective, value-based care. Recent studies show that MSK conditions are among the leading contributors to disability in the U.S., highlighting…

chief impact officer
View episode

As healthcare challenges become more complex, the role of a chief impact officer in healthcare systems is gaining unprecedented importance. Healthcare Rethink Host Brian Urban explores the growing significance of this role with Lorena Zimmer, the Chief Impact Officer at Denver Health. From her early days as a tobacco program specialist to her current…

review
View episode

Leveraging data to refine and enhance the promotional material review (MLR) process has become crucial in the ever-evolving landscape of life sciences. Organizations striving for efficiency and compliance need to understand how best to utilize available data to impact their workflow and overall success significantly. How can organizations use data to improve their MLR…